ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.071,92
1,07%
Dow Jones
38.279,91
0,99%
Euro vs US Dollar
1,07281
0,10%
Bitcoin
59.300,29
1,82%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) News

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANIP
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202422h30GlobeNewswire Inc.ANI Pharmaceuticals to Participate at Two Upcoming Healthcare ConferencesNASDAQ:ANIPANI Pharmaceuticals Inc
18/04/202422h05GlobeNewswire Inc.ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
09/04/202412h50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Baclofen Oral SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
04/04/202412h50GlobeNewswire Inc.ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with SarcoidosisNASDAQ:ANIPANI Pharmaceuticals Inc
03/04/202412h50GlobeNewswire Inc.ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma SymposiumNASDAQ:ANIPANI Pharmaceuticals Inc
27/03/202411h50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPNASDAQ:ANIPANI Pharmaceuticals Inc
09/03/202401h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202423h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202422h26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202403h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202403h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202403h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202403h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
07/03/202422h05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
06/03/202423h58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
06/03/202423h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
06/03/202422h29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
06/03/202422h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
05/03/202423h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
05/03/202401h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202422h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202422h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
01/03/202422h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
29/02/202413h22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
TG
DTE
Deutsche Telekom
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
DBI
MDAX
MDAX
FX
EURJPY
Euro vs Yen
NYSE
XOM
Exxon Mobil
DBI
DAX
DAX
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten